Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| bifidobacterium - Clostridiaceae |
👪
Role of probiotics in the treatment of minimal hepatic encephalopathy in patients with HBV-induced liver cirrhosis. The Journal of international medical research (J Int Med Res ) Vol: 46 Issue 9 Pages: 3596-3604 Pub: 2018 Sep Epub: 2018 May 28 Authors Xia X , Chen J , Xia J , Wang B , Liu H , Yang L , Wang Y , Ling Z , Html Article Publication |
| bifidobacterium - Clostridiaceae |
📓
Screening of Bifidobacteria and Lactobacilli Able to Antagonize the Cytotoxic Effect of Clostridium difficile upon Intestinal Epithelial HT29 Monolayer. Frontiers in microbiology (Front Microbiol ) Vol: 7 Issue Pages: 577 Pub: 2016 Epub: 2016 Apr 22 Authors Valdés-Varela L , Alonso-Guervos M , García-Suárez O , Gueimonde M , Ruas-Madiedo P , Html Article Publication |
| bifidobacterium - Clostridiaceae |
👪
Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. Journal of clinical microbiology (J Clin Microbiol ) Vol: 44 Issue 11 Pages: 4025-31 Pub: 2006 Nov Epub: 2006 Sep 13 Authors Mohan R , Koebnick C , Schildt J , Schmidt S , Mueller M , Possner M , Radke M , Blaut M , Html Article Publication |
| bifidobacterium - Clostridiaceae |
📓
Bifidobacteria exert species-specific effects on constipation in BALB/c mice. Food & function (Food Funct ) Vol: 8 Issue 10 Pages: 3587-3600 Pub: 2017 Oct 18 Epub: Authors Wang L , Hu L , Xu Q , Jiang T , Fang S , Wang G , Zhao J , Zhang H , Chen W , Publication Publication |
| bifidobacterium - Clostridiaceae |
👪
[Effect of probiotic product containing bifidobacteria and biogel from brown algae on the intestinal microflora and parameters of innate immunity in mice with experimental drug dysbacteriosis]. Voprosy pitaniia (Vopr Pitan ) Vol: 84 Issue 1 Pages: 73-9 Pub: 2015 Epub: Authors Kuznetsova TA , Makarenkova ID , Koneva EL , Aminina NM , Yakush EV , |
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
